Mesoblast (MEOBF) Other Non-Current Assets (2015 - 2026)
Mesoblast's (MEOBF) quarterly Other Non-Current Assets came in at $1.2 million in Q2 2026, down 7.1% year-over-year from $1.3 million in Q2 2025, and up 0.84% quarter-over-quarter from $1.2 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Mesoblast has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $1.2 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 7.1% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $1.2 million (down 7.1% YoY), while the FY2026 annual figure was $1.2 million, down 7.1% from the prior year.
- Other Non-Current Assets came in at $1.2 million for Q2 2026 at Mesoblast, up from $1.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $2.4 million in Q1 2023 to a low of $397000.0 in Q2 2024.
- Average Other Non-Current Assets over 5 years is $1.4 million, with a median of $1.3 million recorded in 2024.
- Year-over-year, Other Non-Current Assets slumped 40.52% in 2024 and soared 226.45% in 2025.
- Over 5 years, Other Non-Current Assets stood at $1.9 million in 2022, then grew by 16.6% to $2.2 million in 2023, then tumbled by 40.52% to $1.3 million in 2024, then fell by 10.43% to $1.2 million in 2025, then increased by 0.84% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.2 million in Q2 2026, $1.2 million in Q4 2025, and $1.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 284,000.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 37.71 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 6.43 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 25.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 4.54 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 7.86 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 708,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 146.15 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 233,000.00 |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.33 Mn |
| Jun 30, 2024 | 397,000.00 |
| Dec 31, 2023 | 2.24 Mn |
| Jun 30, 2023 | 398,000.00 |
| Mar 31, 2023 | 2.39 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | 413,000.00 |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 1.96 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 451,000.00 |
| Mar 31, 2021 | 3.20 Mn |
| Dec 31, 2020 | 3.21 Mn |
| Sep 30, 2020 | 3.33 Mn |
| Jun 30, 2020 | 3.31 Mn |
| Mar 31, 2020 | 3.24 Mn |